Existence of an iron-oxidizing bacterium Acidithiobacillus ferrooxidans resistant to organomercurial compounds.
Acidithiobacillus ferrooxidans MON-1 which is highly resistant to Hg2+ could grow in a ferrous sulfate medium (pH 2.5) with 0.1 microM p-chloromercuribenzoic acid (PCMB) with a lag time of 2 d. In contrast, A. ferrooxidans AP19-3 which is sensitive to Hg2+ did not grow in the medium. Nine strains of A. ferrooxidans, including seven strains of the American Type Culture Collection grew in the medium with a lag time ranging from 5 to 12 d. The resting cells of MON-1, which has NADPH-dependent mercuric reductase activity, could volatilize Hg0 when incubated in acidic water (pH 3.0) containing 0.1 microM PCMB. However, the resting cells of AP19-3, which has a similar level of NADPH-dependent mercuric reductase activity compared with MON-1, did not volatilize Hg0 from the reaction mixture with 0.1 microM PCMB. The activity level of the 11 strains of A. ferrooxidans to volatilize Hg0 from PCMB corresponded well with the level of growth inhibition by PCMB observed in the growth experiments. The resting cells of MON-1 volatilized Hg0 from phenylmercury acetate (PMA) and methylmercury chloride (MMC) as well as PCMB. The cytosol prepared from MON-1 could volatilize Hg0 from PCMB (0.015 nmol mg(-1) h(-1)), PMA (0.33 nmol mg(-1) h(-1)) and MMC (0.005 nmol mg(-1) h(-1)) in the presence of NADPH and beta-mercaptoethanol.
Takeuchi
Fumiaki
F
Environmental Management and Safety Section, Health and Environment Center, Okayama University, 3-1-1 Tsushima-naka, Okayama 700-8530, Japan.
Negishi
Atsunori
A
Nakamura
Sosaku
S
Kanao
Tadayoshi
T
Kamimura
Kazuo
K
Sugio
Tsuyoshi
T
D042763:Acidithiobacillus / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D024881:Drug Resistance, Bacterial / Q000502:physiology; D007501:Iron / Q000378:metabolism*; D008190:Lyases / Q000378:metabolism*; D008628:Mercury / Q000378:metabolism*; D009941:Organomercury Compounds / Q000378:metabolism / Q000494:pharmacology; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism*; D013045:Species Specificity; D020245:p-Chloromercuribenzoic Acid / Q000378:metabolism* / Q000494:pharmacology
D009941:Organomercury Compounds; D020245:p-Chloromercuribenzoic Acid; D007501:Iron; D010088:Oxidoreductases; C021551:mercuric reductase; D008190:Lyases; D008628:Mercury